Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Cancer Epidemiology

Caring for a Loved One with Cancer

Cancer Screening Considerations: Balancing the Benefits and Risks

Insight into Cancer Vaccines

What is Merkel Cell Carcinoma?

Cancer Pathophysiology

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Cancer Classification

Effects of Social and Economic Deprivation on Cancer Mortality

Myc Mutations and Cancer

Hot vs Cold: the differences between tumor types

See more featured articles »

Cancer Symptoms

Assay for Monitoring and Treating Malignant Brain Tumors

What is Cancer?

Why are Cancer Cell Lines Useful?

Insights into Oncofertility

TARDIS: The Improved Method of Detecting Breast Cancer

Cancer Pain Management

What is Cancer of Unknown Primary?

Is Cancer a Metabolic Disorder?

Secondary Lung Cancer

Secondary Brain Cancer

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Extracellular Vesicles as Floating Cancer Biomarkers

Pediatric Cancer

Cancer Glossary

Cancer Prognosis

The Effects of Cancer on Family Life

The Biochemistry of Breast Cancer Screening

CDK9 and Cancer

Cancer Research

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Cancer History

What is the Tumor Microenvironment?

What is Immunochemotherapy?

What Role do Biobanks Play in Cancer Research?

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Acidosis and Tumor Progression

Cancer Prevention: Lowering your Risk

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Living with Cancer Pain

Cancer Pain

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Microfluidic cancer treatment screen combined with flow cytometry

Exploiting Enzymes in Cancer Diagnosis and Therapy

Cancer Management

Cutaneous Manifestations of Internal Malignancy

British Pioneers in Cancer Biology

Using Biomarkers to Detect Cancer

Overview of Cell Viability and Cytotoxicity

Investigating the Molecular Mechanisms of Cancer

What is Tumorigenesis?

Transforming Cancer Care through Genomic Testing

What Causes Cancer?

Hypoxia Markers and Their Importance

Metastatic Migration in Cancer may be Influenced by Metabolism

Targeted Cancer Therapies

The Cancer Cell Surface Proteome as a Therapeutic Target

Cancer Diagnosis

Latest Cancer News and Research

Blood test may predict which colorectal cancer patients benefit from chemotherapy

A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to research presented today at the ESMO Gastrointestinal Cancers Congress 2026.

3 Jul 2026

Feeder-free TIL expansion system makes advanced cancer immunotherapy safer

Conventional TIL therapy, clinically validatedrecently with the U.S. Food and Drug Administration approval of lifileucel for advanced melanoma,stillfaces substantial hurdles.

3 Jul 2026

New synthetic grafting material kills bone cancer and regenerates bone

Primary bone tumors, such as osteosarcoma, have seen stagnant survival rates over the past four decades. Surgical removal of the tumor is critical, but local recurrence may occur when tumours are close to vital structures, often resulting in amputation

3 Jul 2026

New breast cancer classification system predicts immunotherapy response success

The advent of immune checkpoint inhibitors (ICIs) has marked a paradigm shift in cancer treatment, yet a significant portion of breast cancer patients fail to respond to these therapies.

3 Jul 2026

Researchers advance fertility options for childhood cancer survivors

Researchers at Karolinska Institutet have demonstrated that it is possible to create early germ cells from preserved testicular tissue of young boys facing cancer therapy.

3 Jul 2026

New AI model improves prediction of cancer immunotherapy success

Cancer immunotherapy drugs known as immune checkpoint inhibitors (ICIs) can be miracle drugs for cancer patients, curing some and turning deadly disease into a manageable chronic condition in others.

3 Jul 2026

Overlooked parasitic disease linked to HIV and cervical cancer risk

New research from Liverpool School of Tropical Medicine (LSTM) has highlighted the need to test millions of women and girls for female genital schistosomiasis (FGS), a neglected disease that can increase the risk of chronic illness, HIV and cervical cancer.

3 Jul 2026

Researchers urge expanded testing for neglected female genital schistosomiasis

2 Jul 2026

First-in-class experimental CAR T-cell therapy shows promise against solid tumors

Researchers with the Charbonneau Cancer Institute at the University of Calgary and McMaster University have identified a unique target present on a specific group of solid cancerous tumors.

2 Jul 2026

Blocking nerve signaling may reduce cancer-associated cachexia

Researchers have uncovered a previously unrecognized pathway linking lung tumor genetics, diet, and the nervous system that drives cancer-associated cachexia, according to a new study in mice.

2 Jul 2026

New genome editing tool unlocks fungi's hidden drug-producing potential

Researchers have spent decades-and billions of dollars-sequencing animal and crop genomes, but fungi have historically been the forgotten middle child of genomics, only noticed when they're ruining bread or colonizing toes.

2 Jul 2026

Lung tumors hijack nervous system to drive cancer-related cachexia

According to the Cleveland Clinic, a quarter of cancer deaths can be attributed to one source: cachexia. Cachexia is a syndrome that accompanies underlying chronic illness and causes unwanted muscle and fat loss, reducing quality of life and sometimes even limiting treatment options.

2 Jul 2026

Tailored drug combinations improve outcomes for treatment-resistant advanced melanoma

A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug combinations based on specific tumor biology to improve outcomes for treatment-resistant advanced melanoma.

2 Jul 2026

New high-throughput biological sensors track cellular lipid molecules

Inside every cell are lipid molecules that make up cellular membranes, helping organelles communicate and respond to stress.

2 Jul 2026

USC scientists target brain inflammation to prevent Alzheimer's disease

An interdisciplinary team at the USC Center for Personalized Brain Health (CPBH) is targeting a family of enzymes that can increase the risk of inflammation in the brains of people with the APOE4 gene variation-the most significant genetic risk factor for late-onset Alzheimer's-as a way to prevent the disease.

2 Jul 2026

Targeted therapy doubles progression-free survival in rare bile duct cancer

Results of the ongoing eNRGy trial, a single-arm, multicenter, global phase 2 clinical trial evaluating zenocutuzumab in solid tumors positive for Neuregulin 1 (NRG1) gene fusions, reported manageable side effects and clinically meaningful efficacy – including a near doubling of progression-free survival compared to expectations with standard of care – in previously treated patients with advanced NRG1-positive cholangiocarcinoma.

2 Jul 2026

Evolutionary noncoding RNAs reveal new targets for cancer therapy

In cancer research, one person's junk is increasingly becoming another person's treasure. Scientists have now uncovered new evidence showing how recently evolved "junk DNA" genetic elements can become integrated into ancient cellular pathways that regulate cancer.

1 Jul 2026

Study potential new therapeutic strategy for patients with ATRX-mutant gliomas

A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common genetic alterations in glioma rewires the cancer cell genome to fuel tumor progression, suggesting a potential new therapeutic strategy for patients with ATRX-mutant gliomas.

1 Jul 2026

Engineered CAR T cells show promise against myeloproliferative neoplasms

A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells unharmed, in new research led by UCL and University of Oxford researchers.

1 Jul 2026

Imaging scans detect prostate cancer progression despite stable PSA levels

Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels of prostate-specific antigen (PSA), a protein in the blood that doctors routinely monitor for cancer progression, according to an analysis led by researchers at Weill Cornell Medicine and Duke University.

1 Jul 2026